Our Focus

Metabolic Diseases.png

Boyle, JG, et al., Clinical Science (2018) 132 1699–1709


图片1.png



Publications


Title
VenueTypeDate
ASC47, An Adipose-Targeted, Muscle-Preserving Weight Loss Drug Candidate For Obesity, Demonstrated Significant Weight Loss And Preserved Muscle In DIO Mice

The 32nd European Congress On Obesity 

(ECO 2025)

Oral5/2025
ASC47, a Muscle-Preserving Weight Loss Drug Candidate in Healthy Participants: A First-in-human Single Ascending Dose Study

The 32nd European Congress On Obesity 

(ECO 2025)

Guided 

poster

5/2025
ASC30, an Oral GLP-1R Biased Small Molecule Agonist in Participants with Obesity—A First-in-Human Single Ascending Dose Study

 The American Diabetes 

Association's 85th 

Scientific Sessions 

(ADA 2025)

Poster6/2025
ASC47, a Muscle-Preserving Weight Loss Drug Candidate for Obesity, in Combination with Semaglutide, Demonstrated Superior Weight Loss to Semaglutide Monotherapy in a Preclinical Model

The American Diabetes 

Association's 85th 

Scientific Sessions 

(ADA 2025)

Poster6/2025